Babies should get new drug that prevents RSV, CDC panel says -
An infection with RSV is a coldlike nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies yet so the new drug, a lab-made antibody that helps the immune system fight off the virus, is expected to fill a critical need.
The drug, developed by AstraZeneca and Sanofi, is expected to be ready in the fall before the RSV season, typically November through March. In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die. A panel of outside advisers to the Centers for Disease Control and Prevention recommended the one-time shot for infants born just before or during the RSV season and for those less than 8 months old before the season starts. They also recommended a dose for some older babies, 8 months to 19 months old, those who are at high risk of a serious illness from RSV.The drug, to be sold under the brand name Beyfortus, is expected to cost $495 per dose, and to be covered by insurers.
In May, the Food and Drug Administration approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns. Although the new drug is not a vaccine, the expert panel also supported including it in Vaccines for Children, a government program providing free immunizations. The American Academy of Pediatrics is urging hospitals to stock Beyfortus so that newborns can get it during RSV season before they go home.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC to meet on FDA-approved RSV vaccine, local mother details twins' health scare last fallRSV is the leading cause of hospitalization in infants under a year old in the United States every year.
Read more »
Vaccines for flu and RSV now available ahead of fall virus season | CNNWith the fall respiratory virus season just around the corner, major US pharmacy chains have begun rolling out flu and RSV vaccine appointments.
Read more »
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccineBoth RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
Read more »
Pfizer Sued By GSK Over Alleged Patent Infringement For Its RSV VaccineBritish drugmaker GlaxoSmithKline is accusing Pfizer of infringing on four of its patents in its RSV vaccine.
Read more »
Pfizer Sued By GSK Over Alleged Patent Infringement For Its RSV VaccineBritish drugmaker GlaxoSmithKline is accusing Pfizer of infringing on four of its patents in its RSV vaccine.
Read more »
Mirvie Receives $4.6 Million Grant From The Gates Foundation To Study Preeclampsia, A Leading Cause Of Maternal Mortality WorldwidePreeclampsia disproportionately impacts mothers and infants in developing countries, affecting 10 million women globally.
Read more »